To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open-
High-
Low-
Prev. Close-
Avg. Traded Price-
Volume-

MARKET DEPTH

info2
Total bid0.00
Total ask0.00
OrdersQtyBid
AskQtyOrders

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

31.892 days ago
31.892 days ago
arrow

LOWER/UPPER CIRCUITS

31.89
35.23
arrow
Venmax Drugs And Pharmaceutica Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 836.81%, in the last year to ₹1.86 Cr. Its sector's average revenue growth for the last fiscal year was 10.5%.
noteQuarterly Revenue,rose 1,063.75% YoY to ₹1.21 Cr. Its sector's average revenue growth YoY for the quarter was 9.69%.
noteQuarterly Net profit,rose 247.91% YoY to ₹0.04 Cr. Its sector's average net profit growth YoY for the quarter was -2.18%.
View more
Venmax Drugs and Pharmaceuticals Limited engages in the manufacture and sale of bulk drugs intermediates primarily in India. It primarily offers trityl chloride. The company formerly known as Yenkey Drugs and Pharmaceuticals Limited was incorporated in 1988 and is based in Hyderabad India.
personal

Grow your wealth with more research recommendations

+91